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Abstract
Background: While occurring enzymatically in biological systems, O-linked glycosylation affects protein folding,
localization and trafficking, protein solubility, antigenicity, biological activity, as well as cell-cell interactions on
membrane proteins. Catalytic enzymes involve glycotransferases, sugar-transferring enzymes and glycosidases
which trim specific monosaccharides from precursors to form intermediate structures. Due to the difficulty of
experimental identification, several works have used computational methods to identify glycosylation sites.
Results: By investigating glycosylated sites that contain various motifs between Transmembrane (TM) and non-
Transmembrane (non-TM) proteins, this work presents a novel method, GlycoRBF, that implements radial basis
function (RBF) networks with significant amino acid pairs (SAAPs) for identifying O-linked glycosylated serine and
threonine on TM proteins and non-TM proteins. Additionally, a membrane topology is considered for reducing the
false positives on glycosylated TM proteins. Based on an evaluation using five-fold cross-validation, the
consideration of a membrane topology can reduce 31.4% of the false positives when identifying O-linked
glycosylation sites on TM proteins. Via an independent test, GlycoRBF outperforms previous O-linked glycosylation
site prediction schemes.
Conclusion: A case study of Cyclic AMP-dependent transcription factor ATF-6 alpha was presented to demonstrate
the effectiveness of GlycoRBF. Web-based GlycoRBF, which can be accessed at http://GlycoRBF.bioinfo.tw, can
identify O-linked glycosylated serine and threonine effectively and efficiently. Moreover, the structural topology of
Transmembrane (TM) proteins with glycosylation sites is provided to users. The stand-alone version of GlycoRBF is
also available for high throughput data analysis.
Background
Protein glycosylation adds an oligosaccharide (chain of
sugars) to a polypeptide (chain of amino acids) in order to
produce a glycoprotein. Many proteins in eukaryotic cells
are glycoproteins since they contain oligosaccharide chains
covalently linked to certain amino acids. Among the pre-
dominant sugars found in glycoproteins include xylose,
fucose, galactose, glucose, mannose, N-acetylglucosamine,
N-acetylgalactosamine, and N-acetylneuraminic acid [1].
Specific carbohydrate epitopes can serve as ligands for
receptors that mediate recognition events [2]. Catalytic
enzymes involve glycotransferases, sugar-transferring
enzymes and glycosidases which trim specific monosac-
charides from precursors to form intermediate structures
[3]. As is well known, glycosylation affect protein folding,
localization and trafficking, protein solubility, antigenicity,
and biological activity, as well as cell-cell interactions
on membrane proteins [4]. Protein glycosylation can
be divided into four main categories mainly depending on
the linkage between the amino acid and the sugar, includ-
ing N-linked glycosylation, O-linked glycosylation,
C-mannosylation and glycophosphatidlyinositol (GPI)
anchor attachments [5].
* Correspondence: yien@csie.org
† Contributed equally
Department of Computer Science and Engineering, Yuan Ze University,
Chungli 320, Taiwan
Chen et al. BMC Bioinformatics 2010, 11:536
http://www.biomedcentral.com/1471-2105/11/536
© 2010 Chen et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.Owing to the difficulty of experimental identification,
several works have computationally identified glycosyla-
tion sites, which could be a feasible means of conduct-
ing preliminary analyses and significantly reducing the
number of potential targets that require further in vivo
or in vitro confirmation. Blom et al.[ 6 ]a r et h ef i r s t
group to propose a method for computationally identify-
ing glycosylation sites. Gupta et al. [7] have proposed
a web-based tool, named NetNGlyc, for identifying
N-glycosylation sites in human proteins. Li et al.[ 8 ]
applied support vector machine (SVM) for predicting
O-glycosylation sites in mammalian proteins. Caragea
et al. [9] have used the ensembles of SVM classifiers to
predict glycosylation sites. Additionally, NetOglyc3.1 [2],
CKSAAP [10], and GPP [11] are well-maintained
O-linked glycosylation prediction web servers. Julenius
et al. [2] combined sequence, surface accessibility, sec-
ondary structure, and distance constraints for building
neural network glycosylation prediction model. Chen
et al. [10] analyzed the k-spaced amino acid pairs of gly-
col-proteins and developed support vector machine
based method to predict O-link glycosylation sites.
Hamby and Hirst [11] adopted the random forests
method, integrating frequencies of amino acids sur-
rounding modified residue and significant pairwise pat-
terns for predicting glycosylation site.
By investigating glycosylated sites that contain various
motifs between transmembrane (TM) proteins and non-
transmembrane (non-TM) proteins, this work presents a
novel method, GlycoRBF, that implements radial basis
function (RBF) networks for identifying O-linked glyco-
sylated sites on TM proteins and non-TM proteins.
Based on statistical measurement, the significant amino
acid pairs (SAAPs) that surround O-linked glycosylation
sites are adopted to improve the prediction perfor-
mance. By combining the identified SAAPs with the
sequence of amino acids, the predictive specificity for
glycosylated TM proteins and non-TM proteins is
greatly improved; this is based on an evaluation using
five-fold cross validation. Additionally, a membrane
topology is considered for reducing the false positives
on glycosylated TM proteins. Via an independent
test, GlycoRBF outperforms previously published
glycosylation site prediction schemes. To investigate the
characteristics of O-linked glycosylation sites in a com-
prehensive manner, 531 physicochemical properties, that
were extracted from version 9.1 of AAindex [12], were
evaluated for its ability to distinguish the glycosylation
sites from the non-glycosylation sites. To demonstrate
the performance of GlycoRBF, a case study of Cyclic
AMP-dependent transcription factor ATF-6 alpha was
presented. Web-based GlycoRBF, which can be accessed
at http://GlycoRBF.bioinfo.tw, can identify O-linked gly-
cosylated serine and threonine effectively and efficiently.
Moreover, the membrane topology of TM proteins with
glycosylation sites is provided to users. The stand-alone
version of GlycoRBF is also available for high through-
put data analysis.
Methods
According to Figure 1, the analyzing flowchart consists
of collecting and preprocessing data, extracting features,
and learning and evaluating models. This work focuses
on identifying O-linked glycosylation sites on Trans-
membrane (TM) and non-Transmembrane (non-TM)
proteins. Following the model learning and evaluation,
the selected models which contain the highest predictive
accuracy are tested on an independent data set. All of
the detailed processes are described as follows.
Data collection and preprocessing
Release 15.0 of UniProt [13], which is the universal
knowledge base of proteins, consists of 839 experimen-
tally verified O-linked glycosylation sites in 239 glyco-
proteins. As shown in Table 1, 202 and 637 O-linked
glycosylation sites are located on 40 TM proteins and
199 non-TM proteins, respectively. The O-linked glyco-
sylation sites occurred mainly on residues of serine and
threonine. In this work, all experimental O-linked glyco-
sylated serine and threonine collected from UniProt are
regarded as positive set of the original data. The amino
acids of serine and threonine that have not been anno-
tated as glycosylation sites on the experimental O-linked
glycoproteins are regarded as negative set of the original
data. Consequently, 2450 and 14234 non-glycosylation
sites are located on TM proteins and non-TM proteins,
respectively. The significant amino acid pairs (SAAPs)
around the O-linked glycosylation sites are identified
based on the original data. These SAAPs are then
adopted to construct the radial basis function (RBF) net-
works for differentiating O-linked glycosylation sites
from non-glycosylation sites on transmembrane and
non-transmembrane proteins. To prevent overestimation
of the predictive performance, homologous sequences
are removed from the dataset by using a window size of
2n+1 for O-linked glycosylation sites. With reference to
the reduction of the homology in the original dataset of
MASA [14], two glycosylated protein sequences with
more than 30% identity were defined as homologous
sequences. Then, two homologous sequences were
specified to re-align the fragment sequences using a
window length of 2n+1, centered on the glycosylated
sites using BL2SEQ [15]. For two fragment sequences
with 100% identity, when the glycosylated sites in
the two proteins are in the same positions, only one
site was kept while the other was discarded. The non-
homologous negative data were generated using the
same approach as positive one.
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trained models may be overestimated owing to the over-
fitting of a training set. The experimental O-linked gly-
cosylation sites of HPRD release 8.0 [16], which were
not included in UniProt [13], are regarded as the inde-
pendent test set and are used to estimate the actual pre-
diction performance. According to Table 1, 4 and 44
O-linked glycosylation sites are located on 9 TM
proteins and 13 non-TM proteins, respectively. Similar
to the extraction of a negative set of training data, a
total of 1,238 and 662 non-glycosylated serines/threo-
nines on TM proteins and non-TM proteins, respec-
tively, are regarded as a negative set of independent test
data. After the evaluation using k-fold cross-validation,
the independent test set is evaluated by using the
trained model with the highest accuracy. Independent
Figure 1 The analyzing flowchart of GlycoRBF.
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Page 3 of 13test sets are utilized not only to demonstrate the effec-
tiveness of the proposed method, but also to evaluate
the performances of other previously proposed O-linked
glycosylation prediction schemes.
Feature extraction
Fragments of amino acids are extracted from positive
and negative training sets using a window of length 2n
+1 that is centered on O-linked glycosylation sites. Dif-
ferent values of n are used to determine the optimal
window length. BLOSUM62 matrix is adopted to repre-
sent the protein primary sequence information as the
basic feature set for learning radial basis function net-
works. A matrix of (2n+1) × m elements is used to
represent each residue of a training dataset, where 2n+1
stands for the window size and m consists of 21 ele-
ments including 20 types of amino acids and one for
terminal signal. Each row of the normalized BLO-
SUM62 matrix is utilized to encode each type of 20
amino acids.
In order to make further investigation of substrate site
specificity, the significant amino acid pairs between
transmembrane (TM) and non-transmembrane (non-
TM) glycoproteins are identified based on statistical
measurement of F-score [17]. Each position surrounding
glycosylation site is calculated a value of F-score. The
F-score of the ith feature is defined as:
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where xi , xi
() + , and xi
() − , denote the average value of
the ith feature in whole, positive, and negative data sets,
respectively; n
+ denotes the number of positive data set
and n
− denotes the number of negative data set; xki ,
() +
denotes the ith feature of the kth positive instance,
and xki ,
() − denotes the ith feature of the kth negative
instance [17].
After the calculation of the F-score value in each posi-
tion around the glycosylated site, the significant position
with highest F-score value is regarded as the starting
point for extracting the significant amino acid pairs. As
shown in Figure 1, the most frequent amino acids in
significant position are determined and used to detect
another frequent amino acid which is located on the
other position. With the determination of one frequent
amino acid on a specific position, another amino acid
on a different position can be defined to generate the
amino acid pair. After the detection of all amino acid
pairs, each identified amino acid pair is calculated
an F-score value, which indicates the significance of
predicting glycosylation sites. To encode the amino acid
pairs, a binary dimension in the features vector is set to
1 if a protein sequence contains the significant amino
acid pair. Based on the results of the k-fold cross-
validation, the ranked significant amino acid pairs can
be added into the features vector one by one (forward
feature selection) until the predictive performance is
maximized.
Model learning and evaluation
In this work, we adopted the QuickRBF package [18] to
construct radial basis function network (RBFN) classi-
fiers. As presented in Additional file 1, Figure S1, a gen-
eral RBFN consists of three layers, namely the input
layer, the hidden layer, and the output layer. The input
layer broadcasts the coordinates of the input vector to
each of the nodes in the hidden layer. Each node in the
hidden layer then produces an activation based on the
associated radial basis kernel function. Finally, each node
in the output layer computes a linear combination of the
activations of the hidden nodes. The general mathemati-
cal form of the output nodes in RBFN is as follows:
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i
k
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where cj(x) denotes the function corresponding to
the j-th output node and is a linear combination of
Table 1 The statistics of experimentally verified O-linked glycosylation sites on transmembrane (TM) proteins and
non-transmembrane (non-TM) proteins
Database Original data
(UniProt release 15.0)
Independent test data
(HPRD release 8.0)
TM proteins non-TM proteins TM proteins non-TM proteins
Number of O-linked glycosylated proteins 40 199 9 13
Number of O-linked glycosylated serine 87 281 7 10
Number of O-linked glycosylated threonine 115 356 7 34
Number of non-glycosylated serine and threonine 2,450 14,234 1,238 662
The experimental O-linked glycosylated proteins extracted from UniProt release 15.0 are regarded as the original data. To evaluate the real performance of the
constructed models, the experimental O-linked glycosylated proteins collected from HPRD release 8.0 are used for independent testing.
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width si;A l s o ,w ji denotes the weight associated with
the correlation between the j-th output node and the
i-th hidden node. In this work, we adopted a fixed
bandwidth (s) of 5, and used all input nodes as centers
(k = n). With its several bioinformatics applications,
classification based on radial basis function (RBF) net-
work has been extensively adopted to predict factors
such as the cleavage sites in proteins [19], inter-residue
contacts [20], protein disorder [21], and discrimination
of b-barrel proteins [22].
Predictive performance of the constructed models is
evaluated by performing five-fold cross validation. The
five-fold cross validation has been performed with the
sequence level. The 239 glycoproteins are divided into
five approximately equal sized subgroups, about 48
sequences in each subgroup. In one round of cross-
validation, a subgroup is regarded as the test set, and
the remaining four subgroups are regarded as the train-
ing set. The RBFN classifier has been done for each fold
separately using the data on training set and evaluated
with the test set. The cross-validation process is
repeated five rounds, with each of five subgroups used
as the test set in turn. Then, the five results are com-
bined to produce a single estimation. The advantage of
five-fold cross-validation is that all original data are
regarded as both training set and test set, and each data
is used for test exactly once [23]. The following mea-
sures of predictive performance of the trained models
are defined. Precision (Pr) = TP/(TP+FP), Sensitivity
(Sn) = TP/(TP+FN), Specificity (Sp) = TN/(TN+FP),
Accuracy (Acc) = (TP + TN)/(TP+FP+TN+FN),
Balanced Accuracy (BAcc) = (Sn+Sp)/2, and
Matthews Correlation Coefficient  MCC ()
=
×−×
+
() ()
(
TP TN FN FP
TP F FN TN FP TP FP TN FN )( )( )( )
,
×+ × + ×+
where TP, TN, FP and FN denote the number of true
positives, true negatives, false positives and false nega-
tives, respectively. Additionally, predictive models are
constructed for an independent test by using the win-
dow size and features that yield the highest accuracy.
Results and discussions
Distribution of O-linked glycosylation sites on
transmembrane proteins
Based on the annotation of a membrane topology in
UniProt [13], the distribution of glycosylated sites on
transmembrane (TM) proteins is investigated. Table 2
summarizes the statistics of structural topology on 40
TM proteins. Six structural topology types are Lumenal
(L), Nucleoplasmic (N), Extracellular (E); Cytoplasmic
(C), Transmembrane (TM), and Signal peptide (S). For
instance, as a nuclear membrane protein, Lamin-B
receptor contains eight transmembrane segments which
cover 27.4% of the sequence length. Table 3 displays the
distribution of O-linked glycosylation sites on TM pro-
teins. It is observed that nearly all of the O-linked glyco-
sylation sites are located in the extracellular region of
cell membrane proteins (87.6%). Furthermore, several
O-linked glycosylation sites are located in luminal and
nucleoplasmic regions which are the structural topology
of non cell membrane proteins. According to the statis-
tics of our dataset, no glycosylation sites are located on
transmembrane regions as these could not be enzymati-
cally accessed by glycotransferases. Therefore, the trans-
membrane regions of a protein can be considered to
reduce the false positive of glycosylation site prediction.
Characterization of O-linked glycosylation sites on
transmembrane proteins and non-transmembrane
proteins
This work focuses on analyzing O-linked glycosylated
serine and threonine residues on TM proteins
and non-TM proteins. Following the removal of homo-
logous sequence of glycosylation sites, as shown in
Table 4, flanking amino acids (-14 ~ +14) of the non-
homologous glycosylated serine and threonine residues
(glycosylation site centered on position 0) are graphi-
cally visualized as sequence logos. WebLogo [24,25] is
adopted to generate the graphical sequence logo for
the relative frequency of the corresponding amino acid
at each position around the glycosylated sites. The
conservation of amino acids that surround the glycosy-
lation sites can then be easily examined. Based on the
sequence logo representation, no amino acids around
the modified sites are obviously conserved. However,
several motifs are slightly varied between glycosylated
TM and non-TM proteins. Thus, the flanking regions
of glycosylation sites are examined to understand that
the significant amino acid pairs differ between TM
proteins and non-TM proteins, based on the F-score
measurement.
Table 5 displays the identified significant amino acid
pairs (SAAPs) flanking the O-linked glycosylated serine
and threonine residues on the transmembrane proteins
and non-transmembrane proteins. Each SAAP has a
corresponding F-score value, implying that a higher
value of F-score has more significant conservation in a
specific dataset. For instance, the pair (+3T, +9E or
+9T) suggests that the threonine (T) on position +3 and
t h eg l u t a m i ca c i d( E )o rt h r e o n i n e( T )o np o s i t i o n
+9 are significant with F-score 0.071 that surround
O-linked glycosylated serine on transmembrane pro-
teins. For the glycosylated TM proteins, 16 SAAPs and
25 SAAPs surround the O-linked glycosylated serine
and threonine residues, respectively. For non-TM
Chen et al. BMC Bioinformatics 2010, 11:536
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Page 5 of 13Table 2 The distribution of structural topology on 40 transmembrane proteins that are extracted from release
15.0 of UniProt
UniProt
ID
Sequence
length
Protein name Number of TM
segment
Percentage of sequence length in specific structural
topology
L N E C TM S Unknown
O08984 620 Lamin-B receptor TM = 8 0.0% 34.4% 0.0% 0.0% 27.4% 0.0% 38.2%
O14786 923 Neuropilin-1 TM = 1 0.0% 0.0% 90.5% 4.8% 2.5% 2.3% 0.0%
O15431 190 High affinity copper uptake protein 1 TM = 3 0.0% 0.0% 33.7% 33.2% 33.2% 0.0% 0.0%
P01375 233 Tumor necrosis factor TM = 1 0.0% 0.0% 76% 15% 9% 0.0% 0.0%
P01589 272 Interleukin-2 receptor alpha chain TM = 1 0.0% 0.0% 80.5% 4.8% 7% 7.7% 0.0%
P01867 404 Ig gamma-2B chain C region TM = 1 0.0% 0.0% 86.6% 8.9% 4.5% 0.0% 0.0%
P02724 150 Glycophorin-A TM = 1 0.0% 0.0% 48% 24% 15.3% 12.7% 0.0%
P02725 133 Glycophorin-A TM = 1 0.0% 0.0% 46.6% 39.0.0% 17.3% 0.0% 0.0%
P02726 120 Glycophorin-A TM = 1 0.0% 0.0% 40.8% 40.0% 19.2% 0.0% 0.0%
P02727 129 Glycophorin-A TM = 1 0.0% 0.0% 50.4% 20.2% 16.3% 13.2% 0.0%
P02786 760 Transferrin receptor protein 1 TM = 1 0.0% 0.0% 88.4% 8.8% 2.8% 0.0% 0.0%
P03138 389 Large envelope protein TM = 4 0.0% 0.0% 63.2% 14.7% 22.1% 0.0% 0.0%
P04441 279 H-2 class II histocompatibility antigen
gamma chain
TM = 1 0.0% 0.0% 80.3% 10.4% 9.3% 0.0% 0.0%
P04921 128 Glycophorin-C TM = 1 0.0% 0.0% 44.5% 36.7% 18.8% 0.0% 0.0%
P05067 770 Amyloid beta A4 protein TM = 1 0.0% 0.0% 88.6% 6.1% 3.1% 2.2% 0.0%
P06028 91 Glycophorin-B TM = 1 0.0% 0.0% 44% 11% 24.2% 20.9% 0.0%
P07204 575 Thrombomodulin TM = 1 0.0% 0.0% 86.4% 6.3% 4.2% 3.1% 0.0%
P07359 626 Platelet glycoprotein Ib alpha chain TM = 1 0.0% 0.0% 78.1% 16% 3.4% 2.6% 0.0%
P07725 236 T-cell surface glycoprotein CD8 alpha
chain
TM = 1 0.0% 0.0% 69.1% 11% 8.9% 11% 0.0%
P08514 1039 Integrin alpha-IIb TM = 1 0.0% 0.0% 92.6% 1.9% 2.5% 3% 0.0%
P08592 770 Amyloid beta A4 protein TM = 1 0.0% 0.0% 88.6% 6.1% 3.1% 2.2% 0.0%
P11279 417 Lysosome-associated membrane
glycoprotein 1
TM = 1 84.9% 0.0% 0.0% 2.9% 5.5% 6.7% 0.0%
P13473 410 Lysosome-associated membrane
glycoprotein 2
TM = 1 84.6% 0.0% 0.0% 2.7% 5.9% 6.8% 0.0%
P13838 378 Leukosialin TM = 1 0.0% 0.0% 59.6% 32.8% 6.1% 1.9% 0.0%
P14221 144 Glycophorin-A TM = 1 0.0% 0.0% 47.9% 36.1% 16.0.0% 0.0% 0.0%
P16150 400 Leukosialin TM = 1 0.0% 0.0% 58.2% 31% 5.8% 4.8% 0.0%
P17404 335 Chondromodulin-1 TM = 1 0.0% 0.0% 0.0% 0.0% 6.3% 0.0% 93.7%
P21583 273 Kit ligand TM = 1 0.0% 0.0% 69.2% 13.2% 8.4% 9.2% 0.0%
P42098 421 Zona pellucida sperm-binding
protein 3
TM = 1 0.0% 0.0% 85.3% 4.5% 5.0.0% 5.2% 0.0%
P51681 352 C-C chemokine receptor type 5 TM = 7 0.0% 0.0% 26.1% 27.0.0% 46.9% 0.0% 0.0%
P61073 352 C-X-C chemokine receptor type 4 TM = 7 0.0% 0.0% 281% 29.8% 42.0.0% 0.0% 0.0%
P80370 383 Protein delta homolog 1 TM = 1 0.0% 0.0% 73.1% 14.6% 6.3% 6.0.0% 0.0%
Q00657 2326 Chondroitin sulfate proteoglycan 4 TM = 1 0.0% 0.0% 94.4% 3.3% 1.1% 1.2% 0.0%
Q01455 230 Membrane protein TM = 3 17.0.0% 0.0% 0.0% 57.4% 25.7% 0.0% 0.0%
Q07287 536 Zona pellucida sperm-binding
protein 4
TM = 1 0.0% 0.0% 91.4% 0.7% 3.9% 3.9% 0.0%
Q09163 385 Protein delta homolog 1 TM = 1 0.0% 0.0% 73.2% 14.5% 6.2% 6.0.0% 0.0%
Q16790 459 Carbonic anhydrase 9 TM = 1 0.0% 0.0% 82.1% 5.2% 4.6% 8.1% 0.0%
Q62765 843 Neuroligin-1 TM = 1 0.0% 0.0% 77.3% 14.8% 2.5% 5.3% 0.0%
Q71M36 566 Chondroitin sulfate proteoglycan 5 TM = 1 0.0% 0.0% 69.4% 21.6% 3.7% 5.3% 0.0%
Q99075 208 Proheparin-binding EGF-like growth
factor
TM = 1 0.0% 0.0% 67.8% 11.5% 11.5% 9.1% 0.0%
Abbreviation: L, Lumenal; N, Nucleoplasmic; E, Extracellular; C, Cytoplasmic; TM, Transmembrane; S, Signal peptide.
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Page 6 of 13proteins, 32 SAAPS and 13 SAAPS are identified for
O-linked glycosylated serine and threonine residues,
respectively. All of the identified SAAPs are combined
with the sequence of amino acids (BLOSUM62) to
increase the prediction accuracy of O-linked glycosyla-
tion sites.
Predictive performance of cross-validation
In this work, 29-mer (-14 ~ +14) is selected as the win-
dow length in the following evaluation and implementa-
tion. Initially, the sequence of amino acids around
O-linked glycosylation sites is encoded using BlOSUM62
matrix and is evaluated in terms of predictive perfor-
mance. Without the classification of TM proteins and
non-TM proteins, the estimated sensitivity, specificity,
accuracy, and balanced accuracy are 58.8%, 84.5%,
83.3%, and 71.6%, respectively. According to Table 6,
the predictive sensitivity,s p e c i f i c i t y ,a c c u r a c y ,a n d
balanced accuracy of glycosylated TM proteins are
65.3%, 81.1%, 79.9%, and 73.2% respectively. Notably,
the negative set of training data is markedly larger than
the positive one, thus, necessitating a consideration of
the balanced accuracy for the skewed dataset. For
O-linked glycosylated non-TM proteins, the predictive
sensitivity, specificity, accuracy, and balanced accuracy
are 56.7%, 85.1%, 83.9%, and 70.9%, respectively.
Combining the significant amino acid pairs with the
sequence of amino acids increases the predictive specifi-
city for glycosylated membrane proteins to 85.1%. The
accuracy and balanced accuracy are improved without
affecting the estimated sensitivity. For non-TM proteins,
both predictive sensitivity and specificity increased to
60.3% and 86.4%, respectively. Consequently, according
to the evaluation of the five-fold cross validation, the
identified significant amino acid pairs can increase the
predictive performance of GlycoRBF.
Effects of considering membrane topology on
transmembrane proteins
This work also investigates the various motifs of O-
linked glycosylation sites between TM proteins and
non-TM proteins. For TM proteins, the membrane
topology can be considered to further increase the pre-
diction accuracy. As for statistics of O-linked glycosyla-
tion sites on TM proteins (Table 3), the transmembrane
region is assumed to reduce the number of false positive
predictions. As shown in Table 6, false positive predic-
tions are reduced from 462 to 317, thereby reducing
false positive data by 31.4% as compared to models that
do not consider membrane topology. Since O-linked
glycosylation sites must be identified from a novel pro-
tein sequence, an effective membrane topology predic-
tion tool, MEMSAT-SVM [26], was firstly applied to
Table 3 The structural distribution of O-linked
glycosylation sites on 40 transmembrane proteins that
are extracted from release 15.0 of UniProt
Type of membrane
topology
Number of O-linked glycosylation
sites
Extracellular 177
Lumenal 22
Nucleoplasmic 1
Cytoplasmic 0
Transmembrane 0
Unknown 2
Table 4 The sequence frequency logos of O-linked glycosylated serine and threonine on transmembrane (TM) proteins
and non-transmembrane (non-TM) proteins that are extracted from release 15.0 of UniProt
Glycosylated residues Number of non-homologous
sites
Number of
proteins
Window
length
Sequence frequency
logo
Glycosylated serine on TM proteins 87 29 -14 ~ +14
Glycosylated serine on non-TM proteins 281 27 -14 ~ +14
Glycosylated threonine on TM proteins 115 118 -14 ~ +14
Glycosylated threonine on non-TM
proteins
356 137 -14 ~ +14
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Page 7 of 13Table 5 The significant amino acid pairs that surround the O-linked glycosylated serine and threonine on
transmembrane (TM) proteins and non-transmembrane (non-TM) proteins that are extracted from release
15.0 of UniProt
O-linked glycosylated serine O-linked glycosylated threonine
TM proteins non-TM proteins TM proteins non-TM proteins
Pair F-score Pair F-score Pair F-score Pair F-score
(+3T, +9E or +9T) 0.071 (+1G,-2E) 0.058 (+5 S,-9 M or -9P) 0.057 (+3P,-1P’) 0.078
(-7T,+2 S or +3S) 0.064 (+1G,-1G) 0.041 (+5 S,-7T or -7S) 0.053 (+1P,-1P’) 0.058
(+5P,+3P or +3T) 0.064 (+1G,+11G) 0.041 (+5P,+9E or +9P) 0.05 (+3P,+1P’) 0.053
(+1T,+4P) 0.056 (+1G,+5G) 0.04 (-7T,-6 S or -6T) 0.049 (-1P,+5P’) 0.053
(+1P,-1P) 0.056 (+1G,-3G) 0.034 (+5E,+1P or +1T or +1V) 0.047 (-4T,+3P’) 0.036
(-7P,-5T) 0.053 (+1G,+10S) 0.034 (+7T,+8 S or +8P) 0.047 (+1P,+5P’) 0.033
(+1G,+8E) 0.049 (+4 S,+5G) 0.032 (-7T,+8T) 0.044 (-4T,-1P’) 0.033
(-7T,-12A or -12S) 0.047 (-1G,-2E) 0.031 (+7T,+10P or +10S) 0.043 (-4T,+14T’) 0.033
(-7T,+6T) 0.047 (-5 S,+12S) 0.029 (-7T,-12S) 0.042 (-4T,+4T’) 0.032
(+1G,-13D) 0.046 (-1P,-3P) 0.028 (+5P,-9T or -9V) 0.042 (+3T,+2A’) 0.031
(+5P,-12S) 0.046 (+4 S,+1G) 0.027 (+1 S,-8 S or -8T) 0.041 (-4T,-10T’) 0.030
(-7P,-10 S or -10T) 0.045 (+1G,+2E) 0.027 (+1T,+11 S or +11P) 0.041 (-4T,+2T’) 0.030
(+3P,+11S) 0.043 (-5 S,+9A) 0.027 (+7P,+12 S or +12T) 0.040 (-1A,+3P’) 0.030
(-7G,+6K or +6H) 0.038 (+9A,-5S) 0.027 (-7 S,+10S) 0.039
(+3T,+10I) 0.036 (+1T,-7T) 0.026 (+7 S,+10S) 0.039
(+1G,-1G) 0.034 (+4P,-3P) 0.025 (+1P,-13Q or -13T) 0.037
(-1G,-3G) 0.025 (-7P,-11 S or -11L) 0.036
(-1P,+3P) 0.025 (+1P,-3P or -3S) 0.036
(-5G,-4D) 0.025 (+5T,+10 S or +10E) 0.036
(-5 S,+2S) 0.024 (+5E,-7 S or -7T) 0.036
(+9A,+12S) 0.024 (+7P,+6D) 0.035
(-5 S,-12T) 0.023 (+1 S,-6 S or -6T) 0.034
(-1G,+9G) 0.021 (-7 S,-13P) 0.033
(-5 S,-7S) 0.019 (+1T,-13L or -13D) 0.030
(-1G,+7S) 0.018 (-10P,+7P or +7E) 0.017
(+4 S,+7S) 0.017
(+4 S,+12S) 0.017
(+4 S,-2E) 0.017
(-1G,+4S) 0.017
(-5G,-6S) 0.017
(+4 S,+14S) 0.016
(-5G,+10S) 0.015
Table 6 The five-fold cross-validation performance of O-linked glycosylation sites on transmembrane (TM) proteins
and non-transmembrane (non-TM) proteins that are extracted from release 15.0 of UniProt
Training features Amino acid (BLOSUM62) Amino acid + SAAPs Amino acid + SAAPs + Membrane topology*
TM proteins non-TM proteins TM proteins non-TM proteins TM proteins
True Positive 132 361 132 384 132
False Positive 462 2124 365 1933 317
True Negative 1988 12110 2085 12301 2133
False Negative 70 276 70 253 70
Sensitivity 65.3% 56.7% 65.3% 60.3% 65.3%
Specificity 81.1% 85.1% 85.1% 86.4% 87.1%
Accuracy 79.9% 83.9% 83.6% 85.3% 85.4%
Balanced Accuracy 73.2% 70.9% 75.2% 73.4% 76.2%
MCC 0.30 0.23 0.34 0.26 0.37
*This process considers the structural topology of transmembrane in the prediction of O-linked glycosylation sites on transmembrane proteins.
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Page 8 of 13discriminate between TM and non-TM proteins and
annotate the structural topology on TM proteins.
Predictive performance of an independent test
Models are evaluated whether they are over-fitted to
their training data or not. This is done by constructing
and using independent sets of data concerning O-linked
glycosylated sites on TM proteins and non-TM proteins
to demonstrate the effectiveness of the RBF models,
which have the highest prediction accuracy. As pre-
sented in Table 7, the balanced accuracies of the pro-
posed method are 60.1% and 70.9% when it is applied to
glycosylated TM proteins and non-TM proteins, respec-
tively. With 14 O-linked glycosylation sites and 1238
non-glycosylation sites on TM proteins, the proposed
model can achieve a sensitivity of 50.0% and a specificity
of 70.2%. For non-TM proteins, there are 44 O-linked
glycosylation sites and 662 non-glycosylation sites, and
the proposed model can achieve a sensitivity of 61.4%
and a specificity of 80.4%. This analysis reveals that the
performance in an independent test is comparable to
that of the cross-validation.
Other O-linked glycosylation predictors were tested
based on independent test sets. According to the results,
GPP [11] has a high estimated sensitivity in identifying
O-linked glycosylation sites but has a low estimated spe-
cificity when applied to independent test sets of TM
proteins. For non-TM proteins, GPP has a balanced per-
formance between sensitivity and specificity. NetO-
glyc3.1 [2] and CKSAAP [10] have poor sensitivity in
identifying O-linked glycosylation sites, but have high
specificity. Owing to a large size of non-glycosylation
site, NetOglyc3.1, which has high estimated specificity,
outperforms other methods in terms of prediction accu-
racy. While considering balanced accuracy, this method
which specifies the degree of significance outperforms
other approaches in term of predicting O-linked glyco-
sylation sites. Also, accord i n gt o[ 2 7 ] ,w eh a v ep e r -
formed paired t-test as our statistical significance test
during different approaches. The p-value of paired t-test
between our proposed method and other methods are
0.024, 0.036, and 0.035, respectively. The p-values show
that our proposed method is statistically different than
other methods.
Implementation of the prediction scheme
In utilizing time-consuming and laboratory-intensive
experimental identification of protein glycosylation sites,
although glycosylated proteins can be identified, pre-
cisely identifying the glycosylated sites on the substrate
is difficult. Therefore, an effective prediction scheme
should be developed to efficiently identify potential
O-linked glycosylation sites. Following evaluation by
cross-validation and an independent test, amino acid
sequences (BLOSUM62) and the significant amino acid
pairs are utilized to construct RBF models in order to
predict the O-linked glycosylation of serine and threo-
nine. As shown in Figure 2, users can submit their
uncharacterized protein sequences and select a specific
TM protein whose structural topology is considered.
The system, named GlycoRBF, returns the predictions
efficiently, including O-linked glycosylated position, the
flanking amino acids, significant amino acid pairs, and
the sequence logo. In particular, the system provides the
structural topology when users select TM-specific mod-
els for predicting the O-linked glycosylation sites. The
stand-alone version of GlycoRBF is also available for
high throughput data analysis.
To demonstrate the performance of GlycoRBF, a case
study was presented. Cyclic AMP-dependent transcrip-
tion factor ATF-6 alpha, which is located in the endo-
plasmic reticulum membrane, has been proposed that
under ER stress the cleaved N-terminal cytoplasmic
domain translocates into the nucleus [28]. As shown in
Figure 3, cyclic AMP-dependent transcription factor
ATF-6 alpha was experimentally confirmed that con-
tains three O-linked glycosylation sites at 474T, 586T,
and 645T [29]. With the annotation of structural
Table 7 Comparison of independent test between GlycoRBF and other methods
Methods GlycoRBF GPP NetOglyc3.1 CKSAAP
O-linked glycosylation sites on TM proteins Sensitivity 50.0% 57.1% 21.4% 28.6%
Specificity 70.2% 38.4% 82.1% 74.2%
Accuracy 70.0% 38.7% 81.4% 73.6%
Balanced Accuracy 60.1% 47.8% 51.7% 51.4%
MCC 0.05 -0.01 0.01 0.01
O-linked glycosylation sites on non-TM proteins Sensitivity 61.4% 54.5% 47.7% 20.5%
Specificity 80.4% 44.1% 82.0% 78.2%
Accuracy 79.2% 44.8% 79.9% 74.6%
Balanced Accuracy 70.9% 49.3% 64.9% 49.4%
MCC 0.24 -0.01 0.18 -0.01
Chen et al. BMC Bioinformatics 2010, 11:536
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Page 9 of 13topology, GlycoRBF could specifically reduce the false
positives and accurately identify the true glycosylated
threonine at position 474, 586, and 645. The conserved
amino acids round 474T and 586T are colored in Figure
3, based on the sequence logo of experimentally verified
O-linked glycosylation site of threonine. Moreover, the
significant amino acid pair, that was used to identify
O-linked glycosylated 645T, is also provided.
Evaluation of physicochemical properties around the
glycosylation sites
Most predictive models are based on the features of
amino acid sequences. However, previous work has uti-
lized 31 informative physicochemical properties to iden-
tify protein ubiquitylation sites [30]. To investigate the
characteristics of O-linked glycosylation sites in a com-
prehensive manner, 531 physicochemical properties
extracted from version 9.1 of AAindex [12] are evalu-
ated to distinguish the glycosylation sites from the non-
glycosylation sites. Based on the measurement of
F-score, Figure 4 indicates that eight physicochemical
properties around O-linked glycosylation sites have sig-
nificantly differential values at position -7, -1, +1, and
+3 (glycosylation site centered on position 0), which
have a similar significance to BLOSUM62-coded amino
acids. For glycosylated TM proteins, the significant phy-
sicochemical properties include linker propensity index
[31], weights for alpha-helix at the window position of 3
[32], relative preference value at N4 [33], propensity of
amino acids within pi-helices [34], helix-coil equilibrium
constant [35], weights for alpha-helix at the window
position of 4 [32], and linker index [36]. Each significant
physicochemical property is combined with the feature
of amino acid sequences for evaluation of the predictive
performance using five-fold cross-validation. As shown
in Table S1 (Additional file 1), the predictive perfor-
mance of integrating physicochemical properties is simi-
lar to the model that only uses the feature of amino
acid sequences.
In the case of glycosylated non-TM proteins, the sig-
nificant physicochemical properties consist of the
number of bonds in the longest chain [37], absolute
entropy, volume [38], side chain volume [39], radius of
gyration of side chain [40], average volume of buried
residue [41], and residue volume [42,43]. Table S2
(Additional file 1) shows that the combination of phy-
sicochemical property and amino acid sequence per-
forms slightly worse than the model that is only
trained with the feature of amino acid sequences. To
further investigate the functions of O-linked glycosy-
lated non-TM proteins, the functional annotations that
are obtained from Gene Ontology [44] are listed in
Table S3 (Additional file 1). Most of the glycosylated
non-TM proteins are associated with blood coagula-
tion, inflammatory response, immune response, cell
adhesion, and transporter.
Figure 2 The user interface of web-based GlycoRBF.
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O-linked glycosylation prediction methods in previous
studies, including NetOglyc3.1 [2], CKSAAP [10], and
GPP [11], do not consider glycosylated protein types.
However, the proposed scheme incorporates significant
amino acid pairs (SAAPs) to increase the prediction
accuracy of O-linked glycosylated sites on transmem-
brane and non-transmembrane proteins. Based on the
method of RBF networks, the cross-validation accuracies
of O-linked glycosylated sites on TM proteins and non-
TM proteins are 83.6% and 85.1%, respectively. When
the structural topology on glycosylated TM proteins is
considered, the prediction accuracy can reach 85.4%,
subsequently reducing false positives by 31.4%. Compar-
ison of the performance of the proposed approach with
that of previous methods reveals that GlycoRBF has the
significantly higher prediction accuracy according to
independent testing. Additionally, GlycoRBF is imple-
mented as an effective web server for predicting the
O-linked glycosylation sites on TM proteins and non-
TM proteins. A case study of Cyclic AMP-dependent
transcription factor ATF-6 alpha was presented to
demonstrate the effectiveness of GlycoRBF. The stand-
alone version of GlycoRBF is also available for high
throughput data analysis.
Although the proposed method can perform accu-
rately and robustly, based on the results of independent
tests, some issues must still be addressed in future work.
First, there are numerous sugars found in glycoproteins
including xylose, fucose, galactose, glucose, mannose,
N-acetylglucosamine, N-acetylgalactosamine, and N-
acetylneuraminic acid [1]. Various catalytic enzymes
involve glycotransferases, sugar-transferring enzymes
and glycosidases, which trim specific monosaccharides
from precursors to form intermediate structures [3].
Therefore, future research should further investigate the
characteristics of O-linked glycosylation sites according
to the sugar types attached on glycosylated sites. Second,
future research should examine the structural prefer-
ences of glycosylated sites in greater detail, especially
in O-linked glycosylated serine and threonine, whose
flanking residues are not conserved. In addition to the
solvent accessible surface area, secondary structure,
B-factor, intrinsic disordered region, protein linker
Figure 3 A case study of human cyclic AMP-dependent transcription factor ATF-6 alpha that contains three O-linked glycosylation
sites at 474T, 586T, and 645T, based on the annotation of HPRD.
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Page 11 of 13region, and other factors at experimental O-linked
glycosylation sites that are located in the protein regions
with PDB entries, should be studied. Finally, the inde-
pendent test sets that are proposed herein are blind to
the trained model during cross-validation, but may not
be to previously proposed predictors. Hence, developing
a benchmark for constructing test sets that are truly
independent of each predictor is a worthwhile task.
Availability
GlycoRBF can be accessed via a web interface, and is
freely available to all interested users at http://GlycoRBF.
bioinfo.tw. The stand-alone version of GlycoRBF is also
available for high throughput data analysis. All of the
data set that is used in this work is also available.
Additional material
Additional file 1: Figure S1. The general architecture of RBFN consisting
of input layer, hidden layer, and output layer. Table S1. The predictive
performance of significant physicochemical properties in glycosylated
transmembrane proteins. Table S2. The predictive performance of
significant physicochemical properties in glycosylated non-
transmembrane proteins. Table S3. Functional analysis of glycosylated
non-transmembrane proteins. Table S4. Independent dataset of
transmembrane protein. Table S5. The distribution of O-linked
glycosylation sites on transmembrane proteins of independent test set.
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